Drug Shortage Report for APO-MONTELUKAST

Last updated on 2020-01-14 History
Report ID 99311
Drug Identification Number 02377608
Brand name APO-MONTELUKAST
Common or Proper name MONTELUKAST
Company Name APOTEX INC
Active Ingredient(s) MONTELUKAST
Strength(s) 4MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL
Packaging size 30 BLS
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-18
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-01-14
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-14 French Compare
v4 2020-01-14 English Compare
v3 2019-11-20 French Compare
v2 2019-11-20 English Compare
v1 2019-11-20 English Compare